No funding sources for the work.

The study was approved by the Ethics Committee Review Board of Peking University Third Hospital and conformed to the Declaration of Helsinki.
1. Settings
NOTE: The icVEP hardware necessitates a reexamination of stimulus conditions for favoring the M-ON pathway using a standard video card with an 8-bit digital-to-analog converter per electron gun.
<ol>
	<li>Click the Test CFG button and select icvep-bc-8.cfg.</li>
	<li>Click the System button, select Configuration &#8594; Test Configuration and then click the Edit Stimulus button. Please ensure that the frame rate is 60 Hz, luminance of the display&#39;s static background is 51 cd/m2, and total cycles are 20.</li>
	<li>To differentiate OAG patients and control subjects, ensure the following conditions: sinusoidal temporal signals of 10 Hz (6 frames per cycle) and 15% positive-contrast (bright, Contrast 7.50%, Luminance Offset 7.50%, Contrast Offset 0.00%).</li>
</ol>
2. Examination
<ol>
	<li>Select the Eye to Test and ensure that the spatial pattern is a 24 x 24 array of isolated-checks to subtend a 11&#176; visual field, with a 2 x 2 array fixation cross without sinusoidal temporal signals, in order to cue facilitated and careful fixation on the center of the screen (Figure 2)9.</li>
	<li>Place the gold cup electrodes filled with electrolytic water-soluble paste at the following midline sites on the scalp based on the international 10-20 system (Figure 3)24. Ensure that the testing distance is 114 cm.</li>
	<li>Click the Start Test button. One run last for 2 s: the first second of this period presents half of the test contrast level (7.50%) as an adaptation condition, and the following second presents the full test contrast (15.0%).</li>
	<li>Note the prompt Error:Outlier from the program and repeat the run when noise is detected and when the electroencephalography (EEG) epoch is rejected.</li>
	<li>Note the EEG data that is displayed on the operator&#39;s monitor when the run is determined to be valid and when the operator is prompted to click Stop Test button in order to reject the data based on reliability.</li>
</ol>
3. Automatic data processing using software
NOTE: The data is calculated by a discrete Fourier transform after EEG signals are recorded.
<ol>
	<li>Note that once the data is accepted, the program will instruct the operator by a Ding sound and automatically initiate the next run until a set of 8 valid runs are accumulated.</li>
	<li>Note that each run produces a fundamental frequency component (FFC), and if one of the FFCs is an outlier relative to the remaining 7, the program will discard that FFC and will prompt the operator to repeat the run until 8 qualified runs are collected.</li>
	<li>Wait for the program to calculate the mean FFC and radius of a 95% confidence circle using the T2circ statistic25 that is automatically produced from the 8 FFCs within a few seconds.</li>
	<li>Ensure that the individual and mean FFC values, confidence circle, and signal-to-noise ratio (SNR) are automatically displayed on the monitor within less than 1 min after the end of the test (Figure 4A).</li>
</ol>
4. Flowchart for assessing reliability of results
<ol>
	<li>Ensure that the refractive error is corrected to adapt for a distance of 114 cm.</li>
	<li>Ensure that intraocular pressure (IOP) is &#8804; 30 mmHg on the day of examination.</li>
	<li>Ensure that pupil diameters are &#8805; 2 mm and without mydriasis.</li>
	<li>Ensure that each subject rest and is quiet &#8805; 30 min before examination.</li>
	<li>To avoid the influence of a study curve, first check the right eye, then left eye; then, check the right and left eyes again, and record this second result.</li>
	<li>Initiate a retest after at least a 30 min rest when the R-value (nosing ring radius) between both eyes shows a difference of &#62; 0.2, which means the result is unreliable as mood swings.</li>
</ol>

<ol>
	<li>Quigley, H. A., Dunkelberger, G. R., Green, W. R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Chronic+human+glaucoma+causing+selectively+greater+loss+of+large+optic+nerve+fibers.">Chronic human glaucoma causing selectively greater loss of large optic nerve fibers.</a> Ophthalmology. 95, 357-363 (1988).</li><li>Quigley, H. A., Dunkelberger, G. R., Green, W. R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Retinal+ganglion+cell+atrophy+correlated+with+automated+perimetry+in+human+eyes+with+glaucoma.">Retinal ganglion cell atrophy correlated with automated perimetry in human eyes with glaucoma.</a> American Journal of Ophthalmology. 107, 453-464 (1989).</li><li>Bjerre, A., Grigg, J. R., Parry, N. R. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Test-retest+variability+of+multifocal+visual+evoked+potential+and+SITA+standard+perimetry+in+glaucoma.">Test-retest variability of multifocal visual evoked potential and SITA standard perimetry in glaucoma.</a> Investigative Ophthalmology &amp; Visual Science. 45, 4035-4040 (2004).</li><li>Hood, D. C., Zhang, X., Greenstein, V. C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=An+interocular+comparison+of+the+multifocal+VEP:+a+possible+technique+for+detecting+local+damage+to+the+optic+nerve.">An interocular comparison of the multifocal VEP: a possible technique for detecting local damage to the optic nerve.</a> Investigative Ophthalmology &amp; Visual Science. 41, 1580-1587 (2000).</li><li>Klistorner, A. I., Graham, S. L. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Objective+perimetry+in+glaucoma.">Objective perimetry in glaucoma.</a> Ophthalmology. 107, 2299 (2000).</li><li>Graham, S. L., Klistorner, A. I., Goldberg, I. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Clinical+application+of+objective+perimetry+using+multifocal+visual+evoked+potentials+in+glaucoma+practice.">Clinical application of objective perimetry using multifocal visual evoked potentials in glaucoma practice.</a> Archives of Opthalmology. 123, 729-739 (2005).</li><li>Porciatti, V., Ventura, L. M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Normative+data+for+a+user-friendly+paradigm+for+pattern+electroretinogram+recording.">Normative data for a user-friendly paradigm for pattern electroretinogram recording.</a> Ophthalmology. 111, 161-168 (2004).</li><li>Ventura, L. M., Porciatti, V., Ishida, K. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Pattern+electroretinogram+abnormality+and+glaucoma.">Pattern electroretinogram abnormality and glaucoma.</a> Ophthalmology. 112, 10-19 (2005).</li><li>Zemon, V., Tsai, J. C., Forbes, M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Novel+electrophysiological+instrument+for+rapid+and+objective+assessment+of+magnocellular+deficits+associated+with+glaucoma.">Novel electrophysiological instrument for rapid and objective assessment of magnocellular deficits associated with glaucoma.</a> Documenta Ophthalmologica. 117, 233-243 (2008).</li><li>Gupta, N., Ang, L. C., de Tilly, L. N. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Human+glaucoma+and+neural+degeneration+in+intracranial+optic+nerve,+lateral+geniculate+nucleus,+and+visual+cortex.">Human glaucoma and neural degeneration in intracranial optic nerve, lateral geniculate nucleus, and visual cortex.</a> British Journal of Ophthalmology. 90, 674-678 (2006).</li><li>Hartline, H. K. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=The+discharge+of+impulses+in+the+optic+nerve+of+Pecten+in+response+to+illumination+of+the+eye.">The discharge of impulses in the optic nerve of Pecten in response to illumination of the eye.</a> Journal of Cellular and Comparative Physiology. 2, 465-478 (1938).</li><li>Schiller, P. H., Sandell, J. H., Maunsell, J. H. R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Functions+of+the+ON+and+OFF+channels+of+the+visual+system.">Functions of the ON and OFF channels of the visual system.</a> Nature. 322, 824-825 (1986).</li><li>Kaplan, E., Shapley, R. M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=The+primate+retina+contains+two+types+of+ganglion+cells,+with+high+and+low+contrast+sensitivity.">The primate retina contains two types of ganglion cells, with high and low contrast sensitivity.</a> Proceedings of the National Academy of Sciences. 83, 2755-2757 (1986).</li><li>Dacey, D. M., Petersen, M. R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Dendritic+field+size+and+morphology+of+midget+and+parasol+ganglion+cells+of+the+human+retina.">Dendritic field size and morphology of midget and parasol ganglion cells of the human retina.</a> Proceedings of the National Academy of Sciences. 89, 9666-9670 (1992).</li><li>Quigley, H. A., Gregory, R., Dunkelberger, G. R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Chronic+human+glaucoma+causing+selectively+greater+loss+of+large+optic+nerve+fibers.">Chronic human glaucoma causing selectively greater loss of large optic nerve fibers.</a> Ophthalmology. 95, 357-363 (1998).</li><li>Kerrigan-Baumrind, L. A., Quigley, H. A., Pease, M. E. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Number+of+ganglion+cells+in+glaucoma+eyes+compared+with+threshold+visual+field+tests+in+the+same+persons.">Number of ganglion cells in glaucoma eyes compared with threshold visual field tests in the same persons.</a> Investigative Ophthalmology &amp; Visual Science. 41, 741-748 (2000).</li><li>Xiang, F., Lingling, W., Zhizhong, M., Gege, X., Feng, L. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Usefulness+of+frequency-doubling+technology+for+perimetrically+normal+eyes+of+open-angle+glaucoma+patients+with+unilateral+field+loss.">Usefulness of frequency-doubling technology for perimetrically normal eyes of open-angle glaucoma patients with unilateral field loss.</a> Ophthalmology. 117 (8), 1530-1537 (2010).</li><li>Zemon, V., Gordon, J., Welch, J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Asymmetries+in+ON+and+OFF+visual+pathways+of+humans+revealed+using+contrast-+evoked+cortical+potentials.">Asymmetries in ON and OFF visual pathways of humans revealed using contrast- evoked cortical potentials.</a> Visual Neuroscience. 1, 145-150 (1988).</li><li>Zemon, V., Gordon, J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Spatial+tuning+characteristics+of+functional+subsystems+in+the+visual+pathways+of+humans.">Spatial tuning characteristics of functional subsystems in the visual pathways of humans.</a> Investigative Ophthalmology &amp; Visual Science. 29 (Suppl), 297 (1988).</li><li>Zemon, V., Siegfried, J., Gordon, J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Magno+and+Parvo+pathways+in+humans+studied+using+VEPs+to+luminance+and+chromatic+contrast.">Magno and Parvo pathways in humans studied using VEPs to luminance and chromatic contrast.</a> Investigative Ophthalmology &amp; Visual Science. 32, 1033 (1991).</li><li>Zemon, V., Eisner, W., Gordon, J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Contrast-dependent+responses+in+the+human+visual+system:+childhood+through+adulthood.">Contrast-dependent responses in the human visual system: childhood through adulthood.</a> International Journal of Neuroscience. 80, 181-201 (1995).</li><li>Greenstein, V. C., Seliger, S., Zemon, V. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Visual+evoked+potential+assessment+of+the+effects+of+glaucoma+on+visual+subsystems.">Visual evoked potential assessment of the effects of glaucoma on visual subsystems.</a> Vision Research. 38, 1901-1911 (1988).</li><li>Zemon, V., Gordon, J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Luminance+contrast+mechanisms+in+humans:+visual+evoked+potentials+and+a+nonlinear+model.">Luminance contrast mechanisms in humans: visual evoked potentials and a nonlinear model.</a> Vision Research. 46, 4163-4180 (2006).</li><li>Xiang, F., Lingling, W., Xia, D., Tong, D., Aihua, D. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Applications+of+Isolated-Check+Visual+Evoked+Potential+in+Early+Stage+of+Open-Angle+Glaucoma+Patients.">Applications of Isolated-Check Visual Evoked Potential in Early Stage of Open-Angle Glaucoma Patients.</a> Chinese Medical Journal. 131 (20), 2439-2446 (2018).</li><li>Victor, J. D., Mast, J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=A+new+statistic+for+steady-state+evoked+potentials.">A new statistic for steady-state evoked potentials.</a> Electroencephalography and Clinical Neurophysiology. 78 (5), 378-388 (1991).</li><li>Badr, A. A., Zemon, V. M., Greenstein, V. C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=M-+versus+P-function:+Relationship+to+visual+field+loss+in+patients+with+open+angle+glaucoma.">M- versus P-function: Relationship to visual field loss in patients with open angle glaucoma.</a> Investigative Ophthalmology &amp; Visual Science. 44 (13), 50 (2003).</li><li>Kamantigue, M. E., Joson, P. J., Chen, P. P. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Prediction+of+visual+field+defects+on+standard+automated+perimetry+by+screening+C-20-1+frequency+doubling+technology+perimetry.">Prediction of visual field defects on standard automated perimetry by screening C-20-1 frequency doubling technology perimetry.</a> Journal of Glaucoma. 15, 35-39 (2006).</li><li>Richard, P. M., Donald, L. B., Paul, P. L. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Categorizing+the+stage+of+glaucoma+from+pre-diagnosis+to+end-stage+disease.">Categorizing the stage of glaucoma from pre-diagnosis to end-stage disease.</a> American Journal of Ophthalmology. 141 (1), 27 (2006).</li><li>Brandt, J. D., Beiser, J. A., Kass, M. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Central+corneal+thickness+in+the+Ocular+Hypertension+Treatment+Study+(OHTS).">Central corneal thickness in the Ocular Hypertension Treatment Study (OHTS).</a> Ophthalmology. 108 (10), 1779-1788 (2001).</li><li>Medeiros, F. A., Sample, P. A., Weinreb, R. N. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Frequency+doubling+technology+perimetry+abnormalities+as+predictors+of+glaucomatous+visual+field+loss.">Frequency doubling technology perimetry abnormalities as predictors of glaucomatous visual field loss.</a> American Journal of Ophthalmology. 137, 863-871 (2004).</li><li>Yu, Z., Lingling, W., Yanfang, Y. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Potential+of+stratus+optical+coherence+tomography+for+detecting+early+glaucoma+in+perimetrically+normal+eyes+of+open-angle+glaucoma+patients+with+unilateral+visual+field+loss.">Potential of stratus optical coherence tomography for detecting early glaucoma in perimetrically normal eyes of open-angle glaucoma patients with unilateral visual field loss.</a> Journal of Glaucoma. 19 (1), 61-65 (2010).</li><li>Pollack, I., Norman, D. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=A+non-parametric+analysis+of+experiments.">A non-parametric analysis of experiments.</a> Psychonomic Science. 1, 125-126 (1964).</li><li>Salim, S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Influence+of+pupil+size+and+other+test+variables+on+visual+function+assessment+using+visual+evoked+potentials+in+normal+subjects.">Influence of pupil size and other test variables on visual function assessment using visual evoked potentials in normal subjects.</a> Documenta Ophthalmologica. 121 (1), 1-7 (2010).</li><li>Nebbioso, M., Steigerwalt, R. D., Pecori-Giraldi, J., Vingolo, E. M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Multifocal+and+pattern-reversal+visual+evoked+potentials+vs.+automated+perimetry+frequency-doubling+technology+matrix+in+optic+neuritis.">Multifocal and pattern-reversal visual evoked potentials vs. automated perimetry frequency-doubling technology matrix in optic neuritis.</a> Indian Journal of Ophthalmology. 61 (2), 59-64 (2013).</li><li>Hood, D. C., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Initial+arcuate+defects+within+the+central+10+degrees+in+glaucoma.">Initial arcuate defects within the central 10 degrees in glaucoma.</a> Investigative Ophthalmology &amp; Visual Science. 52 (2), 940-946 (2011).</li><li>Hood, D. C., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=The+Nature+of+Macular+Damage+in+Glaucoma+as+Revealed+by+Averaging+Optical+Coherence+Tomography+Data.">The Nature of Macular Damage in Glaucoma as Revealed by Averaging Optical Coherence Tomography Data.</a> Translational Vision Science &amp; Technology. 3 (1), (2012).</li><li>Hood, D. C., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Early+glaucoma+involves+both+deep+local,+and+shallow+widespread,+retinal+nerve+fiber+damage+of+the+macular+region.">Early glaucoma involves both deep local, and shallow widespread, retinal nerve fiber damage of the macular region.</a> Investigative Ophthalmology &amp; Visual Science. 55 (2), 632-649 (2014).</li><li>Pescosolido, N., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Role+of+Protease-Inhibitors+in+Ocular+Diseases.">Role of Protease-Inhibitors in Ocular Diseases.</a> Molecules. 19 (12), 20557-20569 (2014).</li></ol>

All the authors have nothing to disclose.

Different settings of icVEP can stimulate different M-cell pathways and create different EEG signals. Under conditions of high temporal frequency (15 Hz) luminance contrast of icVEP (16% positive-contrast), a study involving 15 OAG patients and 14 normal observers showed a sensitivity of 73.33% and specificity of 100%22. However, one-half of these patients had advanced OAG. Therefore, for early stage OAG, the sensitivity could not be estimated due to the small sample size.
Tsai&#39;s study showed a sensitivity of 78% (conditions of 15% positive-contrast and 10 Hz temporal modulation) and specificity of 100%, with an accuracy of 94% from the ROC curve. These results improved upon Greenstein&#39;s study because of the lower contrast and spatial frequency found in earlier glaucoma patients. Nevertheless, there were less than 11 early stage OAG patients among 18 glaucoma patients (17 open-angle, 1 angle-closure) and 16 controls in the study9.
In the current study, the OAG patients were only those in early stages and included a much larger sample size, which suggests that icVEP is indeed useful for detecting OAG in the &#34;real&#34; early-stage. About 70% of early stage OAG eyes were detected by icVEP, and the SNR of patients was greatly different than that of normal subjects.
A recent study showed that pupil size can affect icVEP results in normal subjects. icVEP values were influenced by pupillary constriction and dilation as well as optical blur33. This suggests that when obtaining icVEP measurements, the influence of pupil size and optical blur should be kept in mind for accurate interpretations. In the current study, pupil size was measured, and it was ensured that all values fell in the normal range. Furthermore, all EEG signals may have been affected by emotions, which yields mostly false positive errors. The current study ensured an IOP of &#8804; 30mmHg on the day of examination to avoid mood swings caused by high pressure. All patients rested for &#8805; 30 min before each examination, and reexamination was also performed to avoid mood effects.
SNR was defined as the ratio of the mean amplitude of the FFC to the radius of the 95% confidence circle. An SNR of &#62; 1 indicated a significant response at the 0.05 level, which implied normal electrophysiological activity in the optic nerve. An SNR of &#8804; 1 indicated a response similar to or weaker than the background noise at the 0.05 level, implying abnormal electrophysiological activity in the optic nerve. However, an SNR of 0.93 was optimal for discrimination of early stage OAG patients and control subjects in the current study using a ROC curve. Therefore, a SNR criterion of 0.93 may distinguish the severity of GON in early stage OAG patients for this study.
More than 50% M cells were in the macular region; thus, if the fovea was stimulated, there was likely a strong signal resulting in SNR &#62; 1. Therefore, the 2 x 2 array fixation cross on the center of the screen without sinusoidal temporal signals was able to cue-facilitate careful fixation as well as avoid false negative errors with poor fixation34. Moreover, recent SD-OCT studies proved that RGCs in the macular region become damaged even in early stages of glaucoma, because proteolysis and secondary axotomy after damage to the optic nerve head may result in RGC apoptosis35,36,37,38.
Analysis of central 16 test points in the current study based on pattern deviations in HFA corresponded to the 5&#176;-10&#176; of Bjerrum areas, where almost one-half of M-cells are distributed10,11,12,13,14. This study showed the numbers of abnormal test points in which different possibility criteria were negatively correlated with SNR (negative R-value); though, only when p &#60; 0.5% was the correlation significant, suggesting that icVEP was able to detect functional abnormalities and reflect the severity of central visual field loss in early stage OAG.
It has been reported that the responses to stimulation of the P-cell and M-ON pathway are severely disrupted in early stages of glaucoma, even without functional involvement of the central visual field test26. However, a limitation of this study is that the icVEP test requires patients with a BCVA value of larger than 0.3, spherical refraction between -6 and +3 diopters, and transparent ocular media. The study only shows the usefulness of icVEP in early OAG eyes with better visual acuity. Therefore, further studies are needed to create better stimulations and define more accurate criteria for OAG eyes with poorer visual acuity. This will help determine if the icVEP can serve as the optimal functional test for discriminating glaucoma suspects as well as pre-perimetrical and early-stages of OAG. Furthermore, another limitation is that the study does not account for differences between dominant and non-dominant eyes. Differences between those pathways and testing of these two eyes may affect the EEG signals. Above all, the flowchart will be improved after further studies are performed.
In summary, icVEP is able to detect glaucomatous visual function abnormalities in almost 70% of early stage OAG patients, with a specificity about 95%. The measured functions correlate with both the severity of central 11&#176; visual field loss of standard automated perimetry and decreases in RNFL thickness as detected by OCT. Therefore, icVEP can serve as a useful and objective electrophysiological visual field functional test for diagnosing early stage OAG.

Open-angle glaucoma (OAG) is a chronic, irreversible disease and one of the leading causes of blindness. Previous studies have shown that visual field tests, which are the current gold standard for glaucomatous visual loss detection, are based on conventional standard automated perimetry (SAP) cannot detect early glaucomatous functional loss until 20%-40% of retinal ganglion cells (RGCs) are damaged1,2. Furthermore, SAP has also been shown to have only moderate test-retest reliability, because it is a subjective psychophysical test and a time-consuming task for patients3.
Objective electrophysiological visual field functional measures have better test-retest reliability when detecting glaucoma. Such measures include the multifocal visual evoked potential (mfVEP) and pattern electroretinogram (pERG). However, the pERG cannot provide topographic information, and the mfVEP is more time-consuming than SAP4,5,6,7,8. Fortunately, the isolated-check visual evoked potential (icVEP) was recently designed as an additional technique to detect glaucomatous damage earlier and faster9.
In the retina, there are several RGC subpopulations such as magnocellular cells (M-cells), parvocellular cells (P-cells), and bistratified cells. They represent parallel pathways for visual information being transmitted to the brain (Figure 1)9,10. To govern the separate perceptions of brightness and darkness, the dichotomy of ON and OFF pathways has been established11,12. Magnocellular ON (M-ON) cells are considerably larger than magnocellular OFF (M-OFF) cells, while M-cells are considerably larger than P-cells in humans13,14. The M-cell pathway mainly conveys low spatial frequency/high temporal frequency information15. Thus, cells involved in the M-ON pathway are sensitive to low levels of luminance contrast and not sensitive to chromatic information with larger diameter axons, which are preferentially damaged in early glaucoma16,17. Therefore, the icVEP produces low spatial frequency/high temporal frequency bright stimuli and records cortical activity primarily initiated by afferents (such as those found in the M-ON pathway) for the early detection of glaucoma18,19,20,21,22,23.

<table><tbody><tr><td>CR-2 AF Digital Non-Mydriatic Retinal Camera</td><td>Canon U.S.A., Inc., Melville, NY, USA</td><td></td><td>Stereoscopic fundus photographs</td></tr><tr><td>DGH 500 PachetteTM</td><td>DGH Technology, Exton, PA, USA</td><td></td><td>ultrasound pachymetry</td></tr><tr><td>HFA II 750i</td><td>Carl Zeiss Meditec Inc., Dublin, CA</td><td></td><td>Humphrey Field Analyzer II</td></tr><tr><td>Neucodia novel electrophysiological instrument</td><td>Huzhou Medconova Medical Technology Co.Ltd., Zhejiang province, P.R. China</td><td></td><td>icVEP</td></tr><tr><td>Spectralis SD-OCT</td><td>Heidelberg Engineering, Heidelberg, Germany</td><td></td><td>OCT</td></tr></tbody></table>

assessing early stage open-angle glaucoma in patients by isolated-check visual evoked potential

Recently, the isolated-check visual evoked potential (icVEP) technique was designed and has been reported to detect glaucomatous damage earlier and faster. It creates low spatial frequency/high temporal frequency bright stimuli and records cortical activity initiated primarily by afferents in the magnocellular ON pathway. This pathway contains neurons with larger volumes and axonal diameters, and it is preferentially damaged in early glaucoma, which can result in visual field loss. The study presented here uses standard operative procedures (SOP) of icVEP to obtain reliable results. It can detect visual function loss using a signal-to-noise ratio (SNR) corresponding to the defects of retinal nerve fiber layer (RNFL) in early stage open-angle glaucoma (OAG). A setting of 10 Hz and condition of 15% positive-contrast (bright) are selected to differentiate OAG patients and control subjects, with each check containing eight runs. Each run persists for 2 s (for 20 total cycles). A flowchart is constructed, which consists of pupil size and intraocular pressure over a 30 min rest period before each examination. Additionally, the testing order of eyes is performed to obtain reliable electroencephalographic signals. VEPs are recorded and analyzed automatically by software, and SNRs are derived based on a multivariate statistic. An SNR of &#8804; 1 is considered abnormal. A receiver-operating-characteristic (ROC) curve is applied to analyze the accuracy of group classification. Then, the SOP is applied in a cross-sectional study, showing that icVEP can detect glaucomatous visual function abnormality in the central visual field in the form of SNR. This value also correlates with the thickness thinning of RNFL and produces high classification accuracy for early stage OAG. Thus, it serves as a useful and objective diagnostic technology for the early detection of glaucoma.

Recent studies showed that the accuracy of icVEP for glaucoma diagnosis ranges from 91%-100%9,22,26. Cross-sectional studies in China are presented here to further evaluate the potential diagnostic value of icVEP for early stage OAG.
Subjects 
Subjects were OAG patients and healthy volunteers recruited by the Department of Ophthalmology, Peking University Third Hospital during 2015 and 2016. Inclusion criteria for OAG patients included the following: 25-75 years of age; best-corrected visual acuity (BCVA) &#60; 0.3 (logarithm of the minimum angle of resolution, log MAR); spherical refraction between -6 and +3 diopters; and transparent ocular media. Additionally, patients showed the presence of OAG (subjects with open-angle, visual field defects corresponding to glaucomatous optic neuropathy [GON], and having normal or elevated IOP without secondary causes), in which the IOP was medically well-controlled and had reliable visual field test results (false positive errors &#8804; 20%, false negative errors &#8804; 20%, fixation losses &#8804; 30%) that showed early glaucomatous visual field defects on SAP.
Inclusion criteria for control subjects included the following: no ocular abnormalities, especially no GON in any eye; and a normal IOP that was never elevated over 21 mmHg. Exclusion criteria included the following: diabetes or any other systemic disease; history of ocular or neurologic disease; unequal pupil diameters and pupil diameters of &#60; 2.0 mm; poor fixation; current use of medications that can affect visual field sensitivity (i.e., ethambutol, hydroxychloroquine, chlorpromazine); and previous history of intraocular surgery or refractory surgery.
Examinations for OAG diagnosis 
For all patients, spectacle corrections were used to decrease possible effects of a blur on visual field sensitivity. At least two reliable SAP tests were performed by the Humphrey Field Analyzer II 30-2 SITA standard program at baseline. The second reliable visual field result obtained was used in this study to minimize learning effects27. An early stage of glaucomatous visual field loss was defined as a mean deviation (MD) of &#8805; -6.00 dB, and with at least one of the following: 1) there existed a cluster of &#8805; 3 points in an expected location of the visual field depressed &#60; 5% level, at least one of which was &#60; 1% level on pattern deviation plot; 2) corrected pattern standard deviation or pattern standard deviation significant were at p &#60; 0.05; 3) glaucoma hemifield test result was &#34;outside normal limits&#34;28.
Baseline examination consisted of tests for visual acuity and refraction, pupil-diameter-measurement with a ruler in natural light, slit-lamp biomicroscopy, gonioscopy, Goldmann applanation tonometry (GAT), and dilated stereoscopic fundus examination in all subjects.
The baseline IOP was measured by GAT during glaucoma service (8 A.M. to 11 A.M. local time) on the day after receiving icVEP test reports. Each patient was also subjected to a central corneal thickness (CCT) measurement using ultrasound pachymetry under topical anesthesia29. An average of five consecutive readings was recorded.
Stereoscopic fundus photographs were obtained from each patient after pupil dilation and evaluated in a masked fashion by two experienced doctors. Discrepancies between the two doctors were either resolved by consensus or adjudication of a third experienced doctor. GON was defined as at least one of the following: 1) the rim-to-disc ratio was &#60; 0.1 in the upper or lower rims; 2) there existed retinal nerve fiber layer (RNFL) defects; 3) optic disc showed splint hemorrhages30,31.
Each patient was also subjected to an optical coherence tomography (OCT) test to confirm RNFL defects corresponding to both stereoscopic photographs and HFA results. The changing of RNFL thickness in temporal superior (TS) quadrant and temporal inferior (TI) quadrant were calculated as follows: changing of RNFL thickness = RNFL thickness value - standard value from database of normal people (Figure 4B).
Statistical analysis 
One eye was randomly selected to be analyzed when both eyes met the inclusion criteria. All the data needed to be established within 3 months for each subject. The SPSS 22.0 statistical package with statistical tests was used as follows: independent sample t-test was used for normally distributed variables; Mann-Whitney U test was used for numeric variables that were not normally distributed; and binomial variables were compared with a Chi-squared test or Fisher&#39;s exact test, when necessary. Receiver-operating-characteristic (ROC) curve analysis was used to estimate prediction accuracy for the presence of glaucomatous damage32. Pearson correlation coefficient was used to analyze correlations between SNR and parameters on OCT as well as between SNR and abnormalities in the central 11&#176; field on SAP. If p &#60; 0.05, differences were considered significant.
Results 
A total of 44 OAG patients and 39 control subjects were included with complete data. None of these subjects complained during the icVEP test. All 83 subjects were Chinese (48 males and 35 females) with an average age of 48.54 &#177; 16.70 years old (range of 25-74 years). No statistical differences existed in age, sex, right/left eye, BCVA, spherical equivalent, or pupil diameter between patients and controls (Table 1, p &#62; 0.05), but SNR was significantly lower in patients than in controls (Table 1, p &#60; 0.05).
Regarding the icVEP results, there were 30 eyes of early OAG patients that were SNR-positive (68.18%) and only two eyes in the control group (5.13%). Using an SNR criterion of 1, icVEP showed a sensitivity of 68.18% and specificity of 94.87% for diagnosing early OAG (calculating an accuracy of 67/83 [80.72%]). However, ROC analysis indicated that an a priori SNR criterion of 0.93 was optimal for discrimination between patients and control subjects (Figure 5). Using an SNR criterion of 0.93, the specificity of the test reached 100% with a sensitivity of 65.90% (calculating an accuracy of 82.10%).
For the patients, abnormalities in the central 11&#176; visual field test (HFA, pattern deviation, central 16 test points; Figure 4C) were calculated by the numbers of abnormal points with different possibility criteria. With a criterion level of p &#60; 0.5, the amount of abnormal test points in the central 11&#176; visual field was significantly negatively correlated with SNR (p &#60; 0.05, r = -0.332, Table 2). Thickness changing of RNFL in the temporal superior quadrant was significantly positively correlated with SNR (p &#60; 0.05, r = 0.370, Table 2), while SAP-MD, SAP-MD of the other eye, thickness changing of RNFL in the temporal inferior quadrant, and baseline IOP and CCT were all not correlated with SNR (p &#62; 0.05, Table 3).
<img alt="Figure 1" class="xfigimg" src="/files/ftp_upload/60673/60673fig1.jpg" /> 
Figure 1: Representation of the isolated-check visual evoked potential evaluating the M-cell pathway. Layers 1 and 2 are involved in the magnocellular pathway. Layers 3, 4, 5, and 6 are involved in the parvocellular pathway. The spaces between these six layers are involved in the bistratified cell pathway. RGC = retinal ganglion cell. <a href="https://jove.unicartagenaproxy.elogim.com/files/ftp_upload/60673/60673fig1large.jpg" target="_blank">Please click here to view a larger version of this figure.</a>
<img alt="Figure 2" class="xfigimg" src="/files/ftp_upload/60673/60673fig2.jpg" /> 
Figure 2: Bright conditions (positive-contrast) on the screen of isolated-check visual evoked potential. This figure has been modified from a previous publication24. <a href="https://jove.unicartagenaproxy.elogim.com/files/ftp_upload/60673/60673fig2large.jpg" target="_blank">Please click here to view a larger version of this figure.</a>
<img alt="Figure 3" class="xfigimg" src="/files/ftp_upload/60673/60673fig3.jpg" /> 
Figure 3: Diagram of isolated-check visual evoked potential examination. GND = grounding electrode; Cz = central midline electrode; Pz = parietal midline electrode; Oz = occipital midline electrode. This figure has been modified from a previous publication24. <a href="https://jove.unicartagenaproxy.elogim.com/files/ftp_upload/60673/60673fig3large.jpg" target="_blank">Please click here to view a larger version of this figure.</a>
<img alt="Figure 4" class="xfigimg" src="/files/ftp_upload/60673/60673fig4.jpg" /> 
Figure 4: Typical results from an early stage open angle glaucoma patient. (A) Abnormal isolated-check visual evoked potential results. (B) Outcomes of peripapillary retinal nerve fiber layer thickness (RNFLT) classification on the report of optical coherence tomography. Changing of RNFLT = RNFLT value (black number). The standard value from a database of normal subjects. (green number in brackets). G = global; N = nasal; T = temporal; NS = nasal superior; TS = temporal superior; NI = nasal inferior; TI = temporal inferior. (C) Central 16 test points of pattern deviation on Humphrey Field Analyzer 30-2 SITA program corresponding to the central 11&#176; visual field. This figure has been modified from a previous publication24. <a href="https://jove.unicartagenaproxy.elogim.com/files/ftp_upload/60673/60673fig4large.jpg" target="_blank">Please click here to view a larger version of this figure.</a>
<img alt="Figure 5" class="xfigimg" src="/files/ftp_upload/60673/60673fig5.jpg" /> 
Figure 5: ROC curve. Shown is a ROC curve (blue) for data collected from the signal-to-noise ratios of isolated-check visual evoked potential in open-angle glaucoma patients and control subjects. <a href="https://jove.unicartagenaproxy.elogim.com/files/ftp_upload/60673/60673fig5large.jpg" target="_blank">Please click here to view a larger version of this figure.</a>
<table border="1" fo:keep-together.within-page="1" fo:keep-with-next.within-page="always">
	<tbody>
		<tr>
			<td></td>
			<td>OAG patients (n=44)</td>
			<td>Control subjects (n=39)</td>
			<td>p</td>
		</tr>
		<tr>
			<td>Age (year)</td>
			<td>51.59&#177;14.98</td>
			<td>44.72&#177;16.88</td>
			<td>0.053*</td>
		</tr>
		<tr>
			<td>Sex (male/female)</td>
			<td>28/16</td>
			<td>20/19</td>
			<td>0.175$</td>
		</tr>
		<tr>
			<td>Right eyes / Left eyes</td>
			<td>20/24</td>
			<td>19/20</td>
			<td>0.770$</td>
		</tr>
		<tr>
			<td>BCVA (log MAR)</td>
			<td>0.04&#177;0.06</td>
			<td>0.01&#177;0.04</td>
			<td>0.093#</td>
		</tr>
		<tr>
			<td>Spherical Equivalent (D)</td>
			<td>-1.80&#177;2.16</td>
			<td>-1.30&#177;2.00</td>
			<td>0.276#</td>
		</tr>
		<tr>
			<td>Pupil Diameters (mm)</td>
			<td>3.43&#177;0.50</td>
			<td>3.46&#177;0.51</td>
			<td>0.789#</td>
		</tr>
		<tr>
			<td>icVEP-SNR</td>
			<td>0.85&#177;0.53</td>
			<td>1.44&#177;0.57</td>
			<td>0.000#</td>
		</tr>
		<tr>
			<td colspan="4">*Independent-sample t test, $Chi-square test, #Mann-Whitney U test</td>
		</tr>
		<tr>
			<td colspan="4">OAG: open-angle glaucoma, BCVA: best-corrected visual acuity; log MAR: logarithm of the minimum angle of resolution; icVEP: isolated-check visual evoked potential; SNR: signal-to-noise ratio</td>
		</tr>
	</tbody>
</table>
Table 1: Clinical characteristics of OAG patients and control subjects at baseline.
<table border="1" fo:keep-together.within-page="1" fo:keep-with-next.within-page="always">
	<tbody>
		<tr>
			<td>Numbers of abnormal test points</td>
			<td>Mean &#177; Std (n=44)</td>
			<td>r</td>
			<td>p*</td>
		</tr>
		<tr>
			<td>When P&#60;5%</td>
			<td>4.20&#177;2.60</td>
			<td>-0.264</td>
			<td>0.099</td>
		</tr>
		<tr>
			<td>When P&#60;2%</td>
			<td>2.83&#177;2.34</td>
			<td>-0.298</td>
			<td>0.061</td>
		</tr>
		<tr>
			<td>When P&#60;1%</td>
			<td>2.08&#177;2.12</td>
			<td>-0.266</td>
			<td>0.097</td>
		</tr>
		<tr>
			<td>When P&#60;0.5%</td>
			<td>1.48&#177;1.80</td>
			<td>-0.332</td>
			<td>0.037</td>
		</tr>
		<tr>
			<td colspan="4">*Pearson correlation test</td>
		</tr>
		<tr>
			<td colspan="4">icVEP: isolated-check visual evoked potential; SNR: signal-to-noise ratio; SAP: standard automated perimetry</td>
		</tr>
	</tbody>
</table>
Table 2: Correlation between icVEP-SNR and abnormalities in central 11&#176; visual field of SAP in open-angle glaucoma patients.
<table border="1" fo:keep-together.within-page="1" fo:keep-with-next.within-page="always">
	<tbody>
		<tr>
			<td></td>
			<td>Mean &#177; Std (n=44)</td>
			<td>r</td>
			<td>p*</td>
		</tr>
		<tr>
			<td>SAP-MD (dB)</td>
			<td>-3.83&#177;1.26</td>
			<td>0.115</td>
			<td>0.457</td>
		</tr>
		<tr>
			<td>SAP-MD of the other eye (dB)</td>
			<td>-4.86&#177;3.94</td>
			<td>-0.15</td>
			<td>0.33</td>
		</tr>
		<tr>
			<td>OCT-Thickness changing of RNFL (&#956;m)</td>
			<td></td>
			<td></td>
			<td></td>
		</tr>
		<tr>
			<td>Temporal Superior quadrant</td>
			<td>-39.31&#177;29.89</td>
			<td>0.37</td>
			<td>0.016</td>
		</tr>
		<tr>
			<td>Temporal Inferior quadrant</td>
			<td>-43.64&#177;29.83</td>
			<td>-0.22</td>
			<td>0.161</td>
		</tr>
		<tr>
			<td>Baseline IOP (mmHg)</td>
			<td>15.48&#177;2.80</td>
			<td>-0.121</td>
			<td>0.435</td>
		</tr>
		<tr>
			<td>CCT (&#956;m)</td>
			<td>523.24&#177;29.64</td>
			<td>0.171</td>
			<td>0.333</td>
		</tr>
		<tr>
			<td colspan="4">*Pearson correlation test</td>
		</tr>
		<tr>
			<td colspan="4">icVEP: isolated-check visual evoked potential; SNR: signal-to-noise ratio; SAP: standard automated perimetry (HFA 30-2 SITA); MD: mean deviation; OCT: optical coherence tomography; RNFL: retinal nerve fiber layer; IOP: intraocular pressure; CCT: central corneal thickness</td>
		</tr>
	</tbody>
</table>
Table 3: Correlation between icVEP-SNR and relating factors in patients with open-angle glaucoma.

Watch this Scientific Journal Video about Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential at JoVE.com

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential

The isolated-check visual evoked potential (icVEP) method is implemented here to assess the magnocellular ON pathway that is initially damaged in glaucoma. The study shows standard operative procedures using icVEP to obtain reliable results. It is proved to serve as a useful objective diagnosing technology for the early detection of glaucoma.

Recently, the isolated-check visual evoked potential (icVEP) technique was designed and has been reported to detect glaucomatous damage earlier and ...

assessing-early-stage-open-angle-glaucoma-patients-isolated-check

Universidad de Cartagena UDEC

Research

JoVE Journal

Neuroscience

6.2K Views.  Peking University Third Hospital. The isolated-check visual evoked potential (icVEP) method is implemented here to assess the magnocellular ON pathway that is initially damaged in glaucoma. The study shows standard operative procedures using icVEP to obtain reliable results. It is proved to serve as a useful objective diagnosing technology for the early detection of glaucoma.

Video: Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential

Recording Horizontal Saccade Performances Accurately in Neurological Patients Using Electro-oculogram

Electro-oculogram (EOG) has been widely used for clinical eye movement recording, especially horizontal saccades, although the video-oculography (VOG) has largely taken the place of it nowadays due to its higher spatial accuracy. However, there are situations in which EOG has clear advantages over VOG, e.g., subjects with narrow eye clefts or having cataract lenses, and patients with movement disorders. The present article shows that if properly implemented, EOG can achieve an accuracy almost as good as VOG with substantial stability for recording, while circumventing problems associated with VOG recording. The present paper describes a practical method for recording horizontal saccades using oculomotor paradigms with high accuracy and stability by EOG in neurological patients. The necessary measures are to use an Ag-AgCl electrode with a wide plastic fringe capable of reducing noise, and to wait for sufficient light adaptation to occur. This waiting period also helps to lower the impedance between the electrodes and the skin, thereby ensuring stable signal recorded as time goes by. Furthermore, re-calibration is performed as needed during the task performance. Using this method, the experimenter can avoid drifts of signals, as well as contamination of artifacts or noise from the electromyogram and electroencephalogram, and can collect sufficient data for clinical evaluation of saccades. Thus when implemented, EOG can still be a method of high practicability that can be widely applied to neurological patients, but may be effective also for studies in normal subjects.

The article describes a practical method for recording horizontal eye movements with high accuracy by electro-oculogram in neurological patients, using a cup Ag-AgCl electrode with a wide plastic fringe. Stable measurement requires proper selection and fixation of electrodes, taking sufficient time for light adaptation to occur, and re-calibration as needed.

Electro-oculogram (EOG) has been widely used for clinical eye movement recording, especially horizontal saccades, although the video-oculography (VOG) has ...

Behavior

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients

In order to follow optic neuritis patients and evaluate the effectiveness of their treatment, a handy, accurate and quantifiable tool is required to assess changes in myelination at the central nervous system (CNS). However, standard measurements, including routine visual tests and MRI scans, are not sensitive enough for this purpose. We present two visual tests addressing dynamic monocular and binocular functions which may closely associate with the extent of myelination along visual pathways. These include Object From Motion (OFM) extraction and Time-constrained stereo protocols. In the OFM test, an array of dots compose an object, by moving the dots within the image rightward while moving the dots outside the image leftward or vice versa. The dot pattern generates a camouflaged object that cannot be detected when the dots are stationary or moving as a whole. Importantly, object recognition is critically dependent on motion perception. In the Time-constrained Stereo protocol, spatially disparate images are presented for a limited length of time, challenging binocular 3-dimensional integration in time. Both tests are appropriate for clinical usage and provide a simple, yet powerful, way to identify and quantify processes of demyelination and remyelination along visual pathways. These protocols may be efficient to diagnose and follow optic neuritis and multiple sclerosis patients.
In the diagnostic process, these protocols may reveal visual deficits that cannot be identified via current standard visual measurements. Moreover, these protocols sensitively identify the basis of the currently unexplained continued visual complaints of patients following recovery of visual acuity. In the longitudinal follow up course, the protocols can be used as a sensitive marker of demyelinating and remyelinating processes along time. These protocols may therefore be used to evaluate the efficacy of current and evolving therapeutic strategies, targeting myelination of the CNS.

Object From Motion (OFM) and Time-constrained stereo protocols are sensitive tools to identify monocular and binocular dynamic visual function deficits, which are uniquely affected in optic neuritis patients. Furthermore, these tests may be used as quantitative noninvasive tools to assess the extent of myelination along visual pathways.

In order to follow optic neuritis patients and evaluate the effectiveness of their treatment, a handy, accurate and quantifiable tool is required to ...

Medicine

Assessing Binocular Central Visual Field and Binocular Eye Movements in a Dichoptic Viewing Condition

Macular degeneration typically results in heterogeneous binocular central visual defects. Currently available approaches to assess central visual field, like the microperimetry, can test only one eye at a time. Therefore, they cannot explain how the defects in each eye affect the binocular interaction and real-world function. Dichoptic stimulus presentation with a gaze-controlled system could provide a reliable measure of monocular/binocular visual fields. However, dichoptic stimulus presentation and simultaneous eye-tracking are challenging because optical devices of instruments that present stimulus dichoptically (e.g., haploscope) always interfere with eye-trackers (e.g., infrared video-based eye-trackers). Therefore, the goals were 1) to develop a method for dichoptic stimulus presentation with simultaneous eye-tracking, using 3D-shutter glasses and 3D-ready monitors, that is not affected by interference and 2) to use this method to develop a protocol for assessing central visual field in subjects with central vision loss. The results showed that this setup provides a practical solution for reliably measuring eye-movements in dichoptic viewing condition. In addition, it was also demonstrated that this method can assess gaze-controlled binocular central visual field in subjects with central vision loss.

Presented here is a protocol for assessing binocular eye movements and gaze-controlled central visual field screening in participants with central vision loss.

Macular degeneration typically results in heterogeneous binocular central visual defects. Currently available approaches to assess central visual field, ...

Monocular Visual Deprivation and Ocular Dominance Plasticity Measurement in the Mouse Primary Visual Cortex

Monocular visual deprivation is an excellent experimental paradigm to induce primary visual cortical response plasticity. In general, the response of the cortex to the contralateral eye to a stimulus is much stronger than the response of the ipsilateral eye in the binocular segment of the mouse primary visual cortex (V1). During the mammalian critical period, suturing the contralateral eye will result in a rapid loss of responsiveness of V1 cells to contralateral eye stimulation. With the continuing development of transgenic technologies, more and more studies are using transgenic mice as experimental models to examine the effects of specific genes on ocular dominance (OD) plasticity. In this study, we introduce detailed protocols for monocular visual deprivation and calculate the change in OD plasticity in mouse V1. After monocular deprivation (MD) for 4 days during the critical period, the orientation tuning curves of each neuron are measured, and the tuning curves of layer four neurons in V1 are compared between stimulation of the ipsilateral and contralateral eyes. The contralateral bias index (CBI) can be calculated using each cell&#39;s ocular OD score to indicate the degree of OD plasticity. This experimental technique is important for studying the neural mechanisms of OD plasticity during the critical period and for surveying the roles of specific genes in neural development. The major limitation is that the acute study cannot investigate the change in neural plasticity of the same mouse at a different time.

Here, we present detailed protocols for monocular visual deprivation and ocular dominance plasticity analysis, which are important methods for studying the neural mechanisms of visual plasticity during the critical period and the effects of specific genes on visual development.

Monocular visual deprivation is an excellent experimental paradigm to induce primary visual cortical response plasticity. In general, the response of the ...

Developmental Biology

Simultaneous ex vivo Functional Testing of Two Retinas by in vivo Electroretinogram System

An In vivo electroretinogram (ERG) signal is composed of several overlapping components originating from different retinal cell types, as well as noise from extra-retinal sources. Ex vivo ERG provides an efficient method to dissect the function of retinal cells directly from an intact isolated retina of animals or donor eyes. In addition, ex vivo ERG can be used to test the efficacy and safety of potential therapeutic agents on retina tissue from animals or humans. We show here how commercially available in vivo ERG systems can be used to conduct ex vivo ERG recordings from isolated mouse retinas. We combine the light stimulation, electronic and heating units of a standard in vivo system with custom-designed specimen holder, gravity-controlled perfusion system and electromagnetic noise shielding to record low-noise ex vivo ERG signals simultaneously from two retinas with the acquisition software included in commercial in vivo systems. Further, we demonstrate how to use this method in combination with pharmacological treatments that remove specific ERG components in order to dissect the function of certain retinal cell types.

Simultaneous ex vivo Functional Testing of Two Retinas by in vivo Electroretinogram System

Ex vivo ERG can be used to record electrical activity of retinal cells directly from isolated intact retinas of animals or humans. We demonstrate here how common in vivo ERG systems can be adapted for ex vivo ERG recordings in order to dissect the electrical activity of retinal cells.

An In vivo electroretinogram (ERG) signal is composed of several overlapping components originating from different retinal cell types, as well as noise ...

Simultaneous Recording of Electroretinography and Visual Evoked Potentials in Anesthetized Rats

The electroretinogram (ERG) and visual evoked potential (VEP) are commonly used to assess the integrity of the visual pathway. The ERG measures the electrical responses of the retina to light stimulation, while the VEP measures the corresponding functional integrity of the visual pathways from the retina to the primary visual cortex following the same light event. The ERG waveform can be broken down into components that reflect responses from different retinal neuronal and glial cell classes. The early components of the VEP waveform represent the integrity of the optic nerve and higher cortical centers. These recordings can be conducted in isolation or together, depending on the application. The methodology described in this paper allows simultaneous assessment of retinal and cortical visual evoked electrophysiology from both eyes and both hemispheres. This is a useful way to more comprehensively assess retinal function and the upstream effects that changes in retinal function can have on visual evoked cortical function.

This protocol describes simultaneous measurement of electroretinogram and visual evoked potentials in anesthetized rats.

The electroretinogram (ERG) and visual evoked potential (VEP) are commonly used to assess the integrity of the visual pathway. The ERG measures the ...

In Vivo Methods to Assess Retinal Ganglion Cell and Optic Nerve Function and Structure in Large Animals

The optic nerve collects axons signals from the retinal ganglion cells and transmits visual signal to the brain. Large animal models of optic nerve injury are essential for translating novel therapeutic strategies from rodent models to clinical application due to their closer similarities to humans in size and anatomy. Here we describe some in vivo methods to evaluate the function and structure of the retinal ganglion cells (RGCs) and optic nerve (ON) in large animals, including visual evoked potential (VEP), pattern electroretinogram (PERG) and optical coherence tomography (OCT). Both goat and non-human primate were employed in this study. By presenting these in vivo methods step by step, we hope to increase experimental reproducibility among different labs and facilitate the usage of large animal models of optic neuropathies.

In Vivo Methods to Assess Retinal Ganglion Cell and Optic Nerve Function and Structure in Large Animals

Here we demostrate several in vivo tests (flash visual evoked potential, pattern electroretinogram and optic coherence tomography) in goat and rhesus macaque to understand the structure and function of the optic nerve and its neurons.

The optic nerve collects axons signals from the retinal ganglion cells and transmits visual signal to the brain. Large animal models of optic nerve injury ...

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Glaucoma, the second leading cause of blindness worldwide, is a heterogeneous group of ocular disorders characterized by structural damage to the optic nerve and retinal ganglion cell (RGC) degeneration, resulting in visual dysfunction by interrupting the transmission of visual information from the eye to the brain. Elevated intraocular pressure is the most important risk factor; thus, several models of ocular hypertension have been developed in rodents by either genetic or experimental approaches to investigate the causes and effects of the disease. Among those, some limitations have been reported such as surgical invasiveness, inadequate functional assessment, requirement of extensive training, and highly variable extension of retinal damage. The present work characterizes a simple, low-cost, and efficient method to induce ocular hypertension in rodents, based on low-temperature, full-circle cauterization of the limbal vascular plexus, a major component of aqueous humor drainage. The new model provides a technically easy, noninvasive, and reproducible subacute ocular hypertension, associated with progressive RGC and optic nerve degeneration, and a unique post-operative clinical recovery rate that allows in vivo functional studies by both electrophysiological and behavioral methods.

The goal of this protocol is to characterize a novel model of glaucomatous neurodegeneration based on 360&#176; thermic cauterization of limbal vascular plexus, inducing subacute ocular hypertension.

Glaucoma, the second leading cause of blindness worldwide, is a heterogeneous group of ocular disorders characterized by structural damage to the optic ...

Binocular Dynamic Visual Acuity in Eyeglass-Corrected Myopic Patients

Current clinical visual assessment mainly focuses on static vision. However, static vision may not sufficiently reflect real-life visual function as moving optotypes are frequently observed daily. Dynamic visual acuity (DVA) might reflect real-life situations better, especially when objects are moving at high speeds. Myopia impacts static uncorrected distance visual acuity, conveniently corrected with eyeglasses. However, due to peripheral defocus and prism effects, eyeglass correction might affect DVA. The present research demonstrates a standard method to examine eyeglass-corrected DVA in myopia patients, and aimed to explore the influence of eyeglass correction on DVA. 
Initially, standard subjective refraction was performed to provide the eyeglass prescription to correct the refractive error. Then, binocular distance vision-corrected DVA was examined using the object-moving DVA protocol. Software was designed to display the moving optotypes according to the preset velocity and size on a screen. The optotype was the standard logarithmic visual chart letter E and moves from the middle of the left to the right side horizontally during the test. Moving optotypes with randomized opening direction for each size are displayed. The subjects were required to identify the opening direction of the optotype, and the DVA is defined as the minimum optotype that subjects could recognize, calculated according to the algorithm of logarithmic visual acuity.
Then, the method was applied in 181 young myopic subjects with eyeglass-corrected-to-normal static visual acuity. Dominant eye, cycloplegic subjective refraction (sphere and cylinder), accommodation function (negative and positive relative accommodation, binocular cross-cylinder), and binocular DVA at 40 and 80 degrees per second (dps) were examined. The results showed that with increasing age, DVA first increased and then decreased. When myopia was fully corrected with eyeglasses, a worse binocular DVA was associated with more significant myopic refractive error. There was no correlation between the dominant eye, accommodation function, and binocular DVA.

The present research demonstrates a method to accurately examine dynamic visual acuity (DVA) in myopic subjects with eyeglass correction. Further analysis indicated that the closer the refraction state to emmetropia, the better the eyeglass-corrected binocular DVA is at both 40 and 80 degrees per second.

Current clinical visual assessment mainly focuses on static vision. However, static vision may not sufficiently reflect real-life visual function as ...

Advancing Visual Cortex Mapping for Enhanced Evaluation of Vision Disorders

Functional Magnetic Resonance Imaging (fMRI) of the Visual Cortex with Wide-View Retinotopic Stimulation

High-resolution retinotopic blood oxygenation level-dependent (BOLD) functional magnetic resonance imaging (fMRI) with a wide-view presentation can be used to functionally map the peripheral and central visual cortex. This method for measuring functional changes of the visual brain allows for functional mapping of the occipital lobe, stimulating &gt;100&#176; (&plusmn;50&#176;) or more of the visual field, compared to standard fMRI visual presentation setups which usually cover &lt;30&#176; of the visual field. A simple wide-view stimulation system for BOLD fMRI can be set up using common MR-compatible projectors by placing a large mirror or screen close to the subject's face and using only the posterior half of a standard head coil to provide a wide-viewing angle without obstructing their vision. The wide-view retinotopic fMRI map can then be imaged using various retinotopic stimulation paradigms, and the data can be analyzed to determine the functional activity of visual cortical regions corresponding to central and peripheral vision. This method provides a practical, easy-to-implement visual presentation system that can be used to evaluate changes in the peripheral and central visual cortex due to eye diseases such as glaucoma and the vision loss that may accompany them.

Author Spotlight: Insights into Visual Cortex Research Through Wide-View fMRI Mapping 

We have developed techniques for mapping the visual cortex function utilizing more of the visual field than is commonly used. This approach has the potential to enhance the evaluation of vision disorders and eye diseases.

High-resolution retinotopic blood oxygenation level-dependent (BOLD) functional magnetic resonance imaging (fMRI) with a wide-view presentation can be ...

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential

Podsumowanie

Przeglądaj więcej filmów

Rozdziały w tym wideo

Recording Horizontal Saccade Performances Accurately in Neurological Patients Using Electro-oculogram

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients

Assessing Binocular Central Visual Field and Binocular Eye Movements in a Dichoptic Viewing Condition

Monocular Visual Deprivation and Ocular Dominance Plasticity Measurement in the Mouse Primary Visual Cortex

Simultaneous ex vivo Functional Testing of Two Retinas by in vivo Electroretinogram System

Simultaneous Recording of Electroretinography and Visual Evoked Potentials in Anesthetized Rats

In Vivo Methods to Assess Retinal Ganglion Cell and Optic Nerve Function and Structure in Large Animals

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Binocular Dynamic Visual Acuity in Eyeglass-Corrected Myopic Patients

Functional Magnetic Resonance Imaging (fMRI) of the Visual Cortex with Wide-View Retinotopic Stimulation